Newsletter - Banner

Breadcrumb

What's New at the RI-MUHC?

Asset Publisher

New study of therapy options in metastatic melanoma

RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors

Nip it in the bud: New study will attack SARS-Cov2 where it multiplies

RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening

Serious Flaws in Studies Linking COVID-19 and Air Pollution

Studies have yet to prove this link, say Carleton and McGill University epidemiologists

Systematic testing of groups at increased risk of SARS-CoV-2: an affordable and reasonable approach

In a new cost-analysis study, researchers recommend widespread testing of priority groups, including healthcare workers, school students and staff...

See more news - RI-MUHC Live

Research Life

Asset Publisher

RI-MUHC researcher Maziar Divangahi honoured by the Royal Society of Canada

Recognition for high-level achievement in research into pulmonary infectious diseases

Lashanda Skerritt awarded Vanier Canada Graduate Scholarship

“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC trainee

Canada Research Chairs Program announces new and renewed chairs

Congratulations to five RI-MUHC researchers!

See more news- Research Life

Close Up

Asset Publisher

Reaching beyond the hallowed halls of academe

“With science under attack, scientists have little choice but to step into the limelight and fight for what matters most” – Dr. Madhukar Pai

See More News - Close Up